Medicine Man Technologies, Inc. - FORM 10-K - EX-32 - CERTIFICATION - March 30, 2020

Attached files

file filename
EX-31.2 - CERTIFICATION - Medicine Man Technologies, Inc.mdcl_ex3102.htm
EX-31.1 - CERTIFICATION - Medicine Man Technologies, Inc.mdcl_ex3101.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Medicine Man Technologies, Inc.mdcl_ex2301.htm
EX-21.1 - LIST OF SUBSIDIARIES - Medicine Man Technologies, Inc.mdcl_ex2101.htm
EX-10.14 - EMPLOYMENT AGREEMENT AS OF AUGUST 12, 2019 BY AND BETWEEN DANIEL PABON AND MEDIC - Medicine Man Technologies, Inc.mdcl_ex1014.htm
EX-10.13 - EMPLOYMENT AGREEMENT AS OF DECEMBER 5, 2019 BY AND BETWEEN BOB DEGABRIELLE AND M - Medicine Man Technologies, Inc.mdcl_ex1013.htm
EX-10.12 - AMENDMENT TO EMPLOYMENT AGREEMENT BY AND BETWEEN NANCY HUBER AND MEDICINE MAN TE - Medicine Man Technologies, Inc.mdcl_ex1012.htm
EX-10.11 - EMPLOYMENT AGREEMENT AS OF DECEMBER 5, 2019 BY AND BETWEEN NANCY HUBER AND MEDIC - Medicine Man Technologies, Inc.mdcl_ex1011.htm
EX-10.10 - EMPLOYMENT AGREEMENT AS OF MARCH 30, 2020 BY AND BETWEEN JUSTIN DYE AND MEDICINE - Medicine Man Technologies, Inc.mdcl_ex1010.htm
EX-4.1 - DESCRIPTION OF CAPITAL STOCK OF MEDICINE MAN TECHNOLOGIES, INC. - Medicine Man Technologies, Inc.mdcl_ex0401.htm
10-K - FORM 10-K - Medicine Man Technologies, Inc.mdcl_10k-123119.htm

Exhibit 32

 

CERTIFICATION PURSUANT TO

18 USC, SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with this annual report of Medicine Man Technologies, Inc. (the “Company”) on Form 10-K for the fiscal year ended December 31, 2019, as filed with the Securities and Exchange Commission on March 30, 2020 (the “Report”), we, the undersigned, in the capacities and on the date indicated below, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of our knowledge:

 

  1. The Report fully complies with the requirements of Rule 13(a) or 15(d) of the Securities Exchange Act of 1934; and
     
  2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

Dated: March 30, 2020 /s/ Justin Dye
  Justin Dye, Chief Executive Officer
   
   
Dated: March 30, 2020 /s/ Nancy Huber
  Nancy Huber, Chief Financial Officer

 

 

Medicine Man Technologies, Inc. Reports